26 noviembre 2014
A major breakthrough in developing a new therapy for advanced bladder cancer — for which there have been no major treatment advances in the past 30 years — has been made by scientists. The study examined an antibody (MPDL3280A) which blocks a protein (PD-L1) thought to help cancer cells evade immune detection.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/wXl56fur-aU/141126133827.htm
